Algo version: 0.98b
Jiangsu Recbio Technology is listed at the HKSE Exchange
Jiangsu Recbio Technology [2179.HK]
HKSE Sector: Healthcare Industry:Biotechnology

Is Jiangsu Recbio Technology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Jiangsu Recbio Technology 10 years ago, but if you had invested on Thursday 31st of March 2022 when the price was HKD25.25, you would have made a loss of HKD-16.55 per share or -65.54%

No, the average daily trading liquidity for Jiangsu Recbio Technology is HKD2 733 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Jiangsu Recbio Technology has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Jiangsu Recbio Technology to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.